INNOGEN-B(02591): Xu Wenjie Resigns as Executive Director
INNOGEN-B(02591) announced that Ms. Xu Wenjie (Ms. Xu) has resigned as an executive director, a member of the strategy committee of the board of directors, and a vice president of the Company, with effect from October 16, 2026, in order to devote more time to her personal affairs; and Mr. Heng Lei (Mr. Heng) has resigned as a non-executive director, with effect from October 16, 2026, in order to devote more time to his personal affairs.
INNOGEN-B (02591) announced that Ms. Xu Wenjie (Ms. Xu) has resigned as an executive director, a member of the strategy committee of the board of directors, and a vice president of the Company, with effect from October 16, 2026, in order to devote more time to her personal affairs; and Mr. Heng Lei (Mr. Heng) has resigned as a non-executive director, with effect from October 16, 2026, in order to devote more time to his personal affairs.
Related Articles
CHINARES PHARMA (03320) subsidiary completes issuance of RMB900 million corporate bonds.
ZGC TEC LEASING (01601) enters into a finance lease agreement for equipment related to pig processing.
HK ENT INTL (08291) will issue 160 million rights shares.
CHINARES PHARMA (03320) subsidiary completes issuance of RMB900 million corporate bonds.
ZGC TEC LEASING (01601) enters into a finance lease agreement for equipment related to pig processing.
HK ENT INTL (08291) will issue 160 million rights shares.
